THC Global expects to complete product validation for Therapeutic Goods Administration (TGA) certified bulk API handling and production at the Southport Facility, as well as the receipt of a permit to commence manufacturing from the Office of Drug Control (ODC) in Q4 2019. This will be followed by commencement of revenue generating production in early 2020.
On completion of validation, the Company will commence formulation of medicinal cannabis products which will be supplied to select study and clinical trials in Australia and Asia.
No hurry of FOMO in near short term imo
THC Global expects to complete product validation for...
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable